Emergent BioSolutions Inc. (DB: ER4) has a market capitalization of $326.10M. Last close €5.60 (as of 2026-10-21); 52-week range €3.81 to €11.72. ORTEX data as of 2026-10-19: short interest is 6.39% of free float, 6,215.9 days to cover and the average cost to borrow is 0.48%.